SSTR-expressing Tumors
1 clinical trials · Condition
◉ Watch SSTR-expressing Tumors
| Record | Firm | Date |
|---|---|---|
| A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies (NCT07621146) | British Columbia Cancer Agency | 2026-09-15 |
Track SSTR-expressing Tumors automatically
Every clearance here is in the API, with alerts when new ones post.